Common genetic risk for Parkinson's disease and dysfunction of the endo-lysosomal system

Noopur Bhore,Erin C. Bogacki,Benjamin O'Callaghan,Helene Plun-Favreau,Patrick A. Lewis,Susanne Herbst

DOI: https://doi.org/10.1098/rstb.2022.0517

2024-02-19

Philosophical Transactions of the Royal Society B Biological Sciences

Abstract:Parkinson's disease is a progressive neurological disorder, characterized by prominent movement dysfunction. The past two decades have seen a rapid expansion of our understanding of the genetic basis of Parkinson's, initially through the identification of monogenic forms and, more recently, through genome-wide association studies identifying common risk variants. Intriguingly, a number of cellular pathways have emerged from these analysis as playing central roles in the aetiopathogenesis of Parkinson's. In this review, the impact of data deriving from genome-wide analyses for Parkinson's upon our functional understanding of the disease will be examined, with a particular focus on examples of endo-lysosomal and mitochondrial dysfunction. The challenges of moving from a genetic to a functional understanding of common risk variants for Parkinson's will be discussed, with a final consideration of the current state of the genetic architecture of the disorder. This article is part of a discussion meeting issue ‘Understanding the endo-lysosomal network in neurodegeneration’.

biology